Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions. [electronic resource]
Producer: 20170619Description: 3105-3114 p. digitalISSN:- 1551-4005
- Apoptosis -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Head and Neck Neoplasms -- metabolism
- Humans
- Models, Biological
- NF-kappa B -- metabolism
- Phthalazines -- pharmacology
- Piperazines -- pharmacology
- Poly Adenosine Diphosphate Ribose -- metabolism
- Poly(ADP-ribose) Polymerase Inhibitors -- pharmacology
- Poly(ADP-ribose) Polymerases -- metabolism
- Signal Transduction -- drug effects
- Treatment Outcome
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.